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Abstract - Congenital cystic adenomatoid 
malformation (CCAM) is a rare congenital lung 
lesion. It may appear since birth (30-35%) with 
difficulty breathing or may have a late onset (60-
65%) with recurring pulmonary infections or 
growth failure; in a small percentage of cases, the 
lesion can be completely asymptomatic.  
Fetal or post-natal surgery can be used as 
surgical treatment of these lesions. Postnatal 
surgery consists of a lobectomy, bilobectomy or 
pneumonectomy, based on the size of the lesion. 
The best age to undergo this surgery is around 2 
years, but only if the injury is stable and the child 
has no complications.  
The study describes three cases of CCAM, 
observed at the Pediatric Surgery Section of the 
University of Siena. We analyzed those 3 cases 
whose approach was defined by the onset of 
symptoms, age and clinical condition of patients. In 
the first case the surgery was performed a few hours 
after birth due to the worsening of the clinical 
conditions; in the other two cases it was delayed 
because the patients were asymptomatic. 
The purpose of this study is to review the 
management of patients with CCAM in relation to 
clinical onset and the type of injury. 
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Congenital cystic adenomatoid malformation 
(CCAM) is a rare hamartomatous lesion of the lung, 
characterized by a cystic mass of dysplastic pulmonary 
tissue with proliferation of bronchial structures to the 
prejudice of alveoli. The lesion can manifest itself with 
the development of respiratory distress, sometimes life 
threatening, or with recurrent pulmonary infections. 
The malformation is usually confined to a single 
lobe, without right or left predominance, and is rarely 
bilateral. The incidence of CCAM varies from 1:25.000 
to 1:35.000, even if a better knowledge of this affection 
makes the diagnosis more frequent (1, 2). 
In 1949 Chin and Tang first reported a case of 
CCAM (3); it was later studied thoroughly by Kwitten 
and Reiner in 1962 and it was classified by Stocker in 
1977 (4). 
The Authors describe three cases of type II 
CCAM, observed at the Section of Pediatric Surgery of 
the University of Siena. The purpose of this study is to 
review the management in relation to the clinical onset 
and the type of the lesion. 
Case 1- F.S., female born at the 39th weeks of 
gestation, by emergency caesarean section due to fetal 
distress (late decelerations detected upon fetal heart-rate 
monitoring). Repeated routine antenatal ultrasound (US) 
examinations were normal. Birth weight was 2.620 g and 
Apgar scores were respectively 6 and 10 at 1 and 5-min. 
A diagnosis of esophageal atresia was suspected since it 
was not possible to pass a nasogastric tube into the 
stomach. On admission to the neonatal intensive care unit 
the general condition was satisfactory, and the baby did 
not require mechanical ventilation. The initial diagnosis 
was confirmed by a plain radiographic examination; 
moreover, the contemporary initial chest 
roentgenograms showed a patchy, nonhomogeneous 
increase in density in the right lower lobe, which was 
interpreted as an aspiration pneumonitis due to the 
oesophageal atresia. Further investigations excluded any 
associated anomalies. Fourteen hours after birth a 
surgical operation was carried out dividing and closing 
the tracheoesophageal fistula and repairing the 
oesophageal atresia. After the operation the infant was 
placed on mechanical ventilation and in total parenteral 
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nutrition. Two days after the operation, a multicystic 
lesion, involving the right lower lobe and resulting in 
heart and mediastinal left shift, became evident at the 





Fig.1 - Chest radiograph: multicystic lesion of the right lower lobe 
with mediastinal left shift. 
 
 
Fig.2 - Computed Tomography: multicystic lesion of the right 
lower lobe. 
 
At 79 hours of life, a sudden change in vital 
signs, with an increase in oxygen requirements, 
tachypnea, cyanosis, a decrease in breath sounds up to 
the left hemitorax, and subcutaneous emphysema took 
place. A chest roentgenogram showed a small right 
pneumothorax, a left tensive pneumothorax, a 
pneumomediastinum, and a pneumoperitoneum. After a 
needle thoracentis, a second thoracotomy was 
undertaken. The lesion appeared to be multilocular, 
confined to the right lower lobe, and in communicating 
with airways. A segmental resection of the lesion was 




Fig.3 - Macroscopic imagine of the lesion. 
  
The hystologic features were compatible with a 
diagnosis of type II CCAM. The postoperative course 
was uneventful, and the infant was discharged at 1 month 
of age. Last follow-up, at 6 years of age, showed normal 
ventilation and oesophageal transit. 
Case 2 - A.A. male born at the 37th week of 
gestation. During 22 weeks of gestation an antenatal 
ultrasound examination showed some “cystic lesions, 12 
mm in diameter, that took upthe whole right lung and 
caused mediastinal shift”; this lesion was found also in 
other two ultrasound examinations undertaken at the 25th 
and 27th gestation weeks. The latest ultrasound 
examinations, at the 33rd and 36th gestation weeks, 
showed a “reduction of iperechogenicity in pulmonar 
right lower lobe; the cystic lesions described before was 
not found”. 
Birth weight was 2.850 g, Apgar score was 3 at 
1-min. The infant immediately required mechanical 
ventilation. Amniotic fluid was sucked from portex, 
stomach and nose. Two days after the delivery the infant 
showed a good metabolic equilibrium, so he was 
extubated. 
Eight days after birth a chest tomography 
showed a “reduced expansion of the lower right lobe, 
with some hyperdiaphan cystic areas, smaller than 1 cm 
in diameter”. Further examinations excluded associated 
anomalies and the child was discharged at 15 days of age 
because of normal growth, good general condition and 
normal clinical objectivity. 
Further tomography examinations, at 2, 6 and 
15 months of age, showed reduction of the cysts in the 
upper segment of the lower right lobe. The last 
examination, at 23 months of age, showed an increase in 
number and diameter of the cysts in the apical segment 
(Picture 4).  
A lower right lobectomy was decided to avoid 
complications, at 24 months of age. Hystological report 




Fig.4 – Hystological report: microscopic images. 
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Fig.5– Histologicalreport: microscopic images 
 
The day after surgery the child was 
hemodinamically stable, apyretic and well reactive, for 
these reasons he was extubated. Three hours later 
respiratory difficulties arose, and the child was 
immediately reintubated. Performing a bronchoscopy 
few secretions at the bronchial right base were found. 
Four days after surgery, the child was extubated 
again but because of broncho spasms and laryngeal 
oedema, arisen 20 minutes later, re-intubation was tried. 
Due to the impossibility to perform this operation a 
tracheotomy was necessary, then removed 6 days later.A 
tracheotomy was necessary due to the impossibility to 
perform this operation,then removed 6 days later. 
Chest radiographs showed a progressive 
expansion of residual lung tissue and a very slight 
pneumothorax in the post-operative period. 
General condition was good, so the child was 
discharged 20 days after surgery. 
At the follow-up, at 1 and 3 months after 
surgery, the child had a good general condition and the 
chest x-ray showed a complete expansion of the lung and 
reabsorption of the pneumothorax. 
Case 3 - G.S., female, born at the 38th weeks of 
gestation; repeated routine antenatal ultrasound (US) 
examinations were normal. Birth weight was 2.960 g and 
Apgar scores wererespectively8 and 10 at 1 and 5-min. 
On admission to the neonatal intensive care unit the 
general condition was satisfactory, and the baby did not 
require mechanical ventilation. The initial diagnosis was 
confirmed by a plain radiographic examination.Eight 
days after birth a chest tomography showed a “reduced 
expansion of the lower left lobe, with some hyperdiaphan 
cystic areas, smaller than 2 cm in diameter”. Further 
examinations excluded associated anomalies and the 
child was discharged at 10 days of age because of normal 
growth, good general condition and normal clinical 
objectivity . 
The lesion appeared to be multilocular, confined 
to the left lower lobe and lingula, and in communicating 
with airways. A resection of lower lobe and lingual was 
performed at 3 years and 8 months of age. It was used a 
thoracoscopic approach with subsequent thoracotomy 




Fig.6 – Thoracoscopic approach. 
 
The histologic features were compatible with a 
diagnosis of type II CCAM. The postoperative course 
was uneventful and the infant was discharged third days 
later. Last follow-up showed normal ventilation and 




CCAM was first classified by Stocker in 1977 
according to the number and the size of cysts, and to 
histology (4, 5, 6). 
CCAM type I (70%) includes single or multiple 
cysts, more than 2 cm in diameter and lined by ciliated 
pseudostratified columnar epithelium. Structures 
resembling normal alveoli lay between the cysts.  
Type II (20%) consists of multiple small cysts 
less than 1 cm in diameter that are lined by ciliated 
cubical to columnar epithelium and creating compression 
of the remaining lung tissue.  
Type III (10%) includes large and non cystic 
malformation that usually produces mediastinal shift. 
Few patients survive at the last one or its associated 
anomalies.  
Recently type IV has been described, with an 
acinar-alveolar type of epithelium like type I 
pneumocytes (7). 
CCAM results from an anomaly of lung 
development between the 5th and 6th weeks of gestation, 
even if etiopathogenesis remains unknown (8, 9, 10, 11). 
CCAM may be associated with other congenital 
anomalies such as: extralobular sequestration, congenital 
diaphragmatic hernia, lung hypoplasia, cardiovascular 
malformations, hydrocephalus, bones malformations, 
oesophageal atresia, bowel atresia, bilateral renal 
agenesia/disgenesia, Pierre-Robin Syndrome, Prune-
Belly Syndrome (12, 13, 4, 7). 
It is interesting to note that recent observations 
have suggested that tracheoesophageal malformations 
and congenital pulmonary defects may share a common 
embryological origin, with an incidence rate of 2,1%. 
This hypothesis may explain, from a pathogenic point of 
view, the association between type II CCAM and 
oesophageal atresia observed in the first case report (13, 
14, 15). 
From a clinical point of view, CCAM may 
present at birth (30-35%) with respiratory distress; 
another group of patients have a late onset (60-65%), 
with recurrent pulmonary infections or growth retard; the 
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lesion can sometimes be completely asymptomatic and 
may only come to attention with a fortuitous X-rays. 
CCAM can be diagnosed by antenatal 
ultrasound examination as early as the 12th week of 
intrauterine life (16, 17, 18). Early diagnosis is very 
important to plan delivery in third level specialist centres, 
to reduce risks due to respiratory distress, and to deal 
with associated malformations. In the first case we 
studied we did not make prenatal diagnosis, so that 
clinical picture developed after iperinsufflation. 
Differential diagnosis includes all lung 
malformations (pulmonary sequestration, lobar 
emphysema, bronchogenic cysts), all the acquired 
inflammatory diseases, staphylococcus pneumopaty, and 
finally traumatic, accidental or iatrogenic emphysema 
and atelectasis.  
The evolution of the lesion may be various. 
Spontaneous prenatal reduction or resolution of CCAM 
is well reported in the Literature, as well as postnatal 
spontaneous and complete resolution (19, 20). In the 
second child a postnatal reduction of the lesion has been 
observed. 
Prognosis of neonatal CCAM is related to early 
diagnosis and relative treatment, so related to prognosis 
of pulmonary resection too. 
Surgical failures, especially in infants with 
respiratory distress, is generally due to hypoplasy of 
controlateral lung, as a result of foetal compression 
operated by the malformed lung (21, 22). 
CCAM is included among the indication of 
foetal surgery. This approach requires a complete and 
careful assessment of mother and foetus’ conditions. 
Selection criteria include hydropic foetus between 24 and 
32 weeks gestation (1, 23, 24). 
Postnatal surgery consists in lobectomy or 
bilobectomy or pneumonectomy if the lesion is bigger. A 
segmentary resection of lung tissue is not well accepted 
even when lesions do not completely take up the lobe 
because cysts isolation and edges identification are very 
difficult. However, as we saw in the first case, if the 
lesion is easy to take out from the lung tissue, the only 
segmentary resection may be performed. 
In the last decade, thanks to technical 
improvement and better instruments, thoracoscopic 
approach have taken a very important role in childhood 
surgery. In fact, it is associated with excellent diagnostic 
and therapeutic results with low mortality rate and high 
benefits. Selection criteria are yet disputed; the efficacy 
of videoassisted procedure should be judged case by case 
(25). 
Most Authors agree that asymptomatic patients 
should be monitored. Infact, if lesions do not show 
progressive growth and children have not recurrent 
respiratory infections, it is better to wait until 2-3 years 
of age to perform surgery. The best age for surgery is 
nearby 2 years: children stand better for thoracotomy, 
have less complications and a better growth ofresidual 
lung tissue. Our approach agrees with the strategies 




CCAM is a rare congenital lesion of the lung; its 
incidence increases due to the large improvement of 
antenatal ultrasound examination. 
We reported on three cases defining therapeutic 
approaches on the grounds of onset, age and clinical 
condition of patients. In fact, in the first case report 
surgery was performed a few hours after delivery due to 
worsening of clinical condition; in the other case report 
surgery was delayed because the child was 
asymptomatic.  
Besides, prenatal diagnosis is very important to 
reduce perinatal risks and to better deal with 
complication that may arise from this malformation. 
Finally, reviewing the Literature we noted an 
agreed attitude to perform surgery between 12 and 24 
months of age in all asymptomatic patients.  
In fact, this range of age implies better 
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